Isoflavones and women's health

about

Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer.Dietary phyto-oestrogens: molecular mechanisms, bioavailability and importance to menopausal health.Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.

P2860

Q36947561-5575C6C6-30A3-453D-9FE0-A7E0D9D0DFD9 Q37350043-E52106B6-FE18-453F-9B3E-639895FDEC91 Q40246475-29521624-9892-465B-B42D-12C394644F47

P2860

Isoflavones and women's health

Item

http://www.wikidata.org/entity/Q24795093

description

2004 nî lūn-bûn

@nan

2004 թուականին հրատարակուած գիտական յօդուած

@hyw

2004 թվականին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Isoflavones and women's health

@ast

Isoflavones and women's health

@en

Isoflavones and women's health

@nl

type

Item

label

Isoflavones and women's health

@ast

Isoflavones and women's health

@en

Isoflavones and women's health

@nl

prefLabel

Isoflavones and women's health

@ast

Isoflavones and women's health

@en

Isoflavones and women's health

@nl

P1476

Isoflavones and women's health

@en

P2093

Trevor Powles

http://www.w3.org/2001/XMLSchema#string

P2860

Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4).

Phyto-oestrogens and Western diseases.

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.

Mammographic densities in a one-year isoflavone intervention.

The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial.

P2888

bcr796

P304

140-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR796

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8619535

http://www.w3.org/2001/XMLSchema#string

P6179

1022529111

http://www.w3.org/2001/XMLSchema#string

P698

15084236

http://www.w3.org/2001/XMLSchema#string

P921

women's health

P932

400685

http://www.w3.org/2001/XMLSchema#string

Isoflavones and women's health

about

P2860

P2860

Isoflavones and women's health

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P921

P932